Proteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%

MT Newswires Live

2025/10/15

Proteomics International Laboratories (ASX:PIQ) secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in Victoria, according to a Wednesday filing with the Australian bourse.

The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.

PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.

Shares rose nearly 3% in morning trade on Wednesday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2575224221"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575224221\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575224221?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-15 08:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575224221","market":"us","top_or_hot":-1,"title":"Proteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> Proteomics International Laboratories (ASX:PIQ) secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>, according to a Wednesday filing with the Australian bourse.</p><p>The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.</p><p>PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.</p><p>Shares rose nearly 3% in morning trade on Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Proteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProteomics International Laboratories Secures Expansion of Collaboration with Victoria University, Hospital; Shares Up 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-15 08:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Proteomics International Laboratories (ASX:PIQ) secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>, according to a Wednesday filing with the Australian bourse.</p><p>The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.</p><p>PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.</p><p>Shares rose nearly 3% in morning trade on Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XKO.AU","symbol_name":"标普/澳交所 300指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2575224221","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575224221","pubTimestamp":1760489844,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Proteomics International Laboratories  secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in Victoria, according to a Wednesday filing with the Australian bourse.The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.Shares rose nearly 3% in morning trade on Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XKO.AU":"标普/澳交所 300指数","PIQ.AU":"PROTEOMICS INTERNATIONAL LAB","XAO.AU":"标普/澳交所 普通股指数","BK4095":"家庭装饰品","XJO.AU":"标普/澳交所 200指数","BK7048":"生命科学工具和服务","BK7508":"医药生物股","VCCTF":"Victoria"},"translate_title":"蛋白质组学国际实验室扩大与维多利亚大学医院的合作；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XKO.AU":0.9,"XJO.AU":0.9,"XAO.AU":0.9,"VCCTF":1.5,"PIQ.AU":1},"content_text":"Proteomics International Laboratories (ASX:PIQ) secured an expansion of its research collaboration with the University of Melbourne and the Royal Women's Hospital in Victoria, according to a Wednesday filing with the Australian bourse.The collaboration aims to validate the company's PromarkerEndo blood test for endometriosis diagnosis and identify tissue-specific biomarkers for future specialized diagnostic tests, the filing said.PromarkerEndo is expected to be launched in Australia in the second half of the year, according to the filing.Shares rose nearly 3% in morning trade on Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}